Search – Page 48 – Indianapolis Business Journal

Home » Search

Articles

After uproar over FDA’s handling of Biogen Alzheimer’s drug, Lilly presses on

July 19, 2021 | John Russell

Even as some drugmakers, including Indianapolis-based Eli Lilly and Co., are pushing to get experimental drugs approved, federal regulators are still dealing with a huge blowback over the controversial way they reviewed a new Alzheimer’s drug by rival Biogen.

Lilly buys California diabetes biotech in deal potentially worth $1 billion

July 14, 2021 | John Russell

The Indianapolis-based drugmaker said the deal to buy Protomer Technologies could be worth up to $1 billion if the technology meets certain milestones. Lilly did not say how much it was paying up front in cash.

Lilly signs deal with California biotech to develop treatments for Lou Gehrig’s disease

July 8, 2021 | John Russell

The collaboration could be worth as much as $694 million and potential royalties to Verge Genomics if the two companies hit development milestones.

Controversial OK of Alzheimer’s drug reignites battle over disease’s cause

July 5, 2021 | The Washington Post

The role of the sticky substance in the brain has long divided researchers and is at the forefront again amid the FDA’s recent clearance of the first drug to treat the disease in almost two decades.

IBJ to launch diversity podcast hosted by attorney Angela Freeman

July 2, 2021 | IBJ Staff

IBJ Publisher Nate Feltman said the podcast is an effort to contribute to a larger community conversation about diversity.

A mighty wind pushes builder IEA into top gear

July 2, 2021 | John Russell

While businesses were laying off employees last year by the boatload because of the pandemic, an Indianapolis company that specializes in building wind and solar farms hired scores of people to tackle new projects nationwide.

Workers are coming back downtown—but not all will be there full time

July 2, 2021 | Susan Orr and Mickey Shuey

Some large downtown employers say they expect most or all of their workforce to return to the office full time. Others say they’re adopting hybrid models that offer employees the option to work remotely at least part of the time.

Lilly and former lobbyist resolve sex discrimination suit

June 30, 2021 | John Russell

In her complaint, the lobbyist had claimed a top executive made sexist comments about her, mocked her physical appearance and subjected her and other women to a hostile work environment.

UPDATE: Lilly to seek FDA approval for potential Alzheimer’s drug

June 24, 2021 | Associated Press and IBJ Staff and Bloomberg News

Eli Lilly and Co. shares jumped more than 9% Thursday morning after it received “breakthrough therapy” designation for donanemab from the U.S. Food and Drug Administration, putting the drug on a path that could expedite its development.

2021 Indiana 100: Taltz leader sees more potential for blockbuster Lilly drug

June 18, 2021 | John Russell

Mathilde Merlet oversees one of Eli Lilly and Co.’s fastest-growing products, a medicine called Taltz that treats a variety of dermatology and rheumatology disorders.

Former surgeon general to join WISH-TV as resident medical expert

June 17, 2021 | IBJ Staff

Dr. Jerome Adams has strong ties to central Indiana, having served as Indiana state health commissioner from 2014 to 2017. After the close of the Trump administration, he returned to the Indianapolis area to practice medicine.

Sources: Rolls-Royce planning to vacate two-thirds of its downtown campus

June 17, 2021 | Mickey Shuey

The United Kingdom-based aircraft engine manufacturer is expected to jettison about 270,000 square feet of office space on its 2.2-acre campus at 450 S. Meridian St. About 3,000 people worked in the company’s downtown offices prior to the pandemic.

Lilly’s COVID therapy hits wall as virus wanes

June 11, 2021 | John Russell

The use of COVID antibodies has fallen across the United States lately and, along with it, Lilly’s sales in that category.

Letters: IU Indianapolis is good name choice

June 11, 2021

If a name change for IUPUI is in order, only the Indiana University name would be of immediate value. Any other name would have to build a reputation over a period of years.

Curt Smith: Indiana poised to emerge from pandemic strong

June 11, 2021 | Curt Smith / Special to IBJ

Many more changes are ahead. Many daunting challenges remain.

Lilly’s stock gets big boost from competitor’s new Alzheimer’s treatment

June 8, 2021 | Bloomberg News

Shares of Biogen competitors soared after aducanumab became the first drug cleared by the U.S. Food and Drug Administration to slow the course of the mind-wasting disease that afflicts 6 million Americans.

Sen. Todd Young’s bill could lead to innovation hub in Indiana

June 4, 2021 | Mickey Shuey

Government and business leaders are preparing to bid to host one of the regional tech hubs that would be created by the U.S. Innovation and Competition Act, even though the bill has yet to pass.

2021 Innovation Issue: Lilly’s disruptive model opens doors to women, minorities

May 28, 2021 | John Russell

For more than a century, Eli Lilly and Co. has pushed for innovation in the pharmaceutical industry. But six years ago, the drugmaker had to admit it was less than innovative in its own workforce.

« Previous 1 … 46 47 48 49 50 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'